Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology

6

Weeks in Review

2

Weeks to Publication
Indexed in KCI, KoreaMed, Synapse, DOAJ
Open Access, Peer Reviewed
pISSN 2288-0585 eISSN 2288-6850

Drug Susceptibility and Clinical Significance of Rapidly Growing Mycobacteria Isolated from Patients with Non-Tuberculous Mycobacteriosis

Original article

Annals of Clinical Microbiology (Ann Clin Microbiol) 2007 October Volume 10, Issue 2, pages 143-149.

https://doi.org/10.5145/ACM.2007.10.2.143

Drug Susceptibility and Clinical Significance of Rapidly Growing Mycobacteria Isolated from Patients with Non-Tuberculous Mycobacteriosis

Jeong Man Kim1, Kyeong Hee Kim1, Sun Min Lee2, Kwang Won Seo3, Joseph Jeong4, Sung-Ryul Kim4, Seon Ho Lee4, Eun Yup Lee2, Chulhun L. Chang2,5
1Department of Laboratory Medicine, Dong-A University College of Medicine, 2Department of Laboratory Medicine, Pusan National University School of Medicine, Busan; Departments of 3Internal Medicine and 4Laboratory Medicine, Ulsan University College of Medicine, Ulsan; 5Korean Institute of Tuberculosis, The Korean National Tuberculosis Association, Seoul, Korea

Abstract

Background: It is recommended that all rapidly growing mycobacteria (RGM) isolated from patients with mycobacteriosis are subjected to antimicrobial susceptibility testing. The current study was aimed to perform susceptibility test on clinical strains of RGM isolated from patients with mycobacteriosis and to determine the clinical significance of the isolates.

Methods: For 17 patients with RGM infection from 2002 to 2006 at Ulsan University Hospital, medical records were reviewed retrospectively and anti-mycobacterial susceptibility test was performed for the clinical isolates by broth microdilution method.

Results: Rates of susceptible strains of RGMs against individual drugs were as follows: amikacin 100%, cefoxitin 59%, ciprofloxacin 82%, clarithromycin 71%, doxycycline 18%, imipenem 91% (M. fortuitum), sulfamethoxazole 71%, and tobramycin 100% (M. chelonae). Ten of the 17 nontuberculous mycobacteria (NTM) patients had been treated with anti-tuberculosis drugs initially. Anti-tuberculosis drugs were continued in 3 patients and changed to other antimicrobial agents effective to NTM in 4 patients, all of whom were cured. Five of 7 NTM patients who had been treated with anti-NTM treatment were cured. All isolates from the patients treated with anti-NTM drugs were susceptible to at least one of the drugs administered.

Conclusion: Clinical isolates of RGMs showed fully susceptible to amikacin, while highly resistant to doxycycline and variable to other drugs depending on the species. (Korean J Clin Microbiol 2007;10:143-149)

Keywords

Nontuberculous mycobacteria, Rapidly growing mycobacteria, Mycobacterium fortuitum, Mycobacterium abscessus, Anti- mycobacterial susceptibility test